Application 202493
- Type
- ANDA
- Sponsor
- MYLAN INSTITUTIONAL
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | CHLOROTHIAZIDE SODIUM | CHLOROTHIAZIDE SODIUM | INJECTABLE;INJECTION | EQ 500MG BASE/VIAL | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 67457-263 | chlorothiazide sodium | chlorothiazide sodium | Mylan Institutional LLC | ANDA | Current |
| 67457-263 | chlorothiazide sodium | chlorothiazide sodium | Mylan Institutional LLC | ANDA | Current |